首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   232842篇
  免费   11501篇
  国内免费   391篇
耳鼻咽喉   3048篇
儿科学   7278篇
妇产科学   4735篇
基础医学   33501篇
口腔科学   5312篇
临床医学   18422篇
内科学   51540篇
皮肤病学   6203篇
神经病学   20805篇
特种医学   7006篇
外国民族医学   101篇
外科学   28917篇
综合类   977篇
一般理论   62篇
预防医学   21201篇
眼科学   4552篇
药学   16380篇
中国医学   698篇
肿瘤学   13996篇
  2023年   1239篇
  2022年   859篇
  2021年   3442篇
  2020年   2053篇
  2019年   3880篇
  2018年   7425篇
  2017年   4869篇
  2016年   4857篇
  2015年   5436篇
  2014年   5660篇
  2013年   9154篇
  2012年   15960篇
  2011年   15918篇
  2010年   7903篇
  2009年   5885篇
  2008年   13678篇
  2007年   14650篇
  2006年   13487篇
  2005年   13347篇
  2004年   12520篇
  2003年   11422篇
  2002年   10817篇
  2001年   6107篇
  2000年   6207篇
  1999年   5510篇
  1998年   883篇
  1997年   731篇
  1996年   700篇
  1992年   3195篇
  1991年   2866篇
  1990年   2733篇
  1989年   2493篇
  1988年   2364篇
  1987年   2194篇
  1986年   2088篇
  1985年   1884篇
  1984年   1396篇
  1983年   1186篇
  1982年   670篇
  1979年   1205篇
  1978年   849篇
  1977年   798篇
  1975年   800篇
  1974年   986篇
  1973年   997篇
  1972年   941篇
  1971年   927篇
  1970年   861篇
  1969年   905篇
  1968年   787篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
75.
76.
77.

Introduction

The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.

Objective

To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.

Methods

Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.

Results

A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.

Conclusion

Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality.  相似文献   
78.
79.
80.
Introduction: The rising prevalence of musculoskeletal pathologies in developed countries has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies is Rheumatoid arthritis (RA), a chronic systemic autoimmune disease that mostly affects the synovium. RA metabolic-associated alterations, including distorted adipokine production, enhance RA inflammatory environment. Among the altered adipokines, visfatin is particularly involved in RA inflammation and catabolism and stands out as an essential enzyme linked to critical cell features.

Areas covered: We discuss the potential mechanism supporting the contribution of visfatin to RA and the association between RA and obesity. We discuss the repurposing of cancer-tested drugs to inhibit visfatin in the context of RA. Additionally, we address the possibility of combining these drugs with current RA therapy. Finally, we explore the future of visfatin as an RA biomarker or therapeutic target.

Expert opinion: Inhibition of visfatin has become an interesting therapeutic approach for RA pathology. Such a feat has already been attained in oncology using small molecule inhibitors, which suggest that a similar course of action would be worth pursuing in the RA context. Visfatin will become an important biomarker and therapeutic target for RA.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号